# Genica

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genica

- Industry: Agribusiness
- Headquarters: Piracicaba, Brazil
- Website: www.genica.com.br
- Total disclosed funding: $1.3M
- Latest round: Series C (Oct 1, 2024)
- Investors on record: 1

## About

Genica is a Brazilian company focused on enhancing agricultural efficiency through innovative bioinputs, including biological pest control and bioinsecticides, aimed at promoting sustainable farming practices.Founded in 2015 and headquartered in Piracicaba, Brazil, Genica specializes in producing bioinputs that support agricultural productivity. The company has engaged in four funding rounds, with its most recent round being a Series C in August 2024, raising BRL 7 million from Rise Life-Centered Investments. The founder's specific background is not detailed; however, the firm has established a solid presence in the agricultural sector, focusing on biological products.Genica specializes in the production of bioinputs aimed at enhancing agricultural efficiency and sustainability. The company's primary offerings include biological pest control agents, bioinsecticides, and inoculants designed to protect crops from pests and diseases while promoting healthier plant growth. These products leverage biological mechanisms to minimize the use of chemical pesticides, addressing consumer demand for cleaner, chemical-free food options. Genica's solutions target farmers and agricultural professionals in Brazil, where demand for biological products is projected to grow significantly by 2025. The company is committed to continuous innovation in the bioinput sector, focusing on developing new generations of bioinsumos that include gene expression technologies and organic molecules for phytosanitary purposes.Genica operates within a rapidly expanding market for biological products, which is expected to see substantial revenue growth. The company's revenue model is centered around direct sales to agricultural producers, with transactions typically occurring through business-to-business (B2B) engagements. Clients include large agricultural enterprises and cooperatives that require reliable bioinput solutions for their crops. Genica's revenue is bolstered by flagship products such as their bioinsecticides and inoculants, which are key to their offering. The pricing structure reflects the high value of these specialized products, designed to improve crop yields and reduce reliance on traditional chemical treatments, thus enhancing the overall productivity of the agricultural sector.In August 2024, Genica raised BRL 7 million in Series C funding from Rise Life-Centered Investments. The company plans to utilize this capital to develop and launch new bioinput products targeting enhanced agricultural performance. Additionally, Genica aims to expand its reach into new markets, focusing on regions where the demand for sustainable agricultural solutions is increasing. Specific details on product release dates or targeted geographic areas for expansion have not been disclosed, but the funding will support these strategic initiatives.

## Funding rounds

- Series C, Oct 1, 2024, $1.3M — Rise Life-Centered Investments

## Investors

- Rise Life-Centered Investments (https://capitalatlas.ai/funds/rise-life-centered-investments) — Series C